Successful treatment of prolonged superior vena cava syndrome with thrombolytic therapy: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8028082.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Superior vena cava (SVC) syndrome is most commonly due to direct compression of the SVC by a tumor. Recently, there has been an increase in the number of cases of SVC syndrome associated with chronic indwelling central venous catheters. We present a case history of a patient with prolonged symptoms of SVC syndrome that was successfully treated with catheter-directed (intraclot) infusion thrombolytic therapy with urokinase. The treatment, prevention, and incidence of SVC syndrome caused by thrombosis associated with catheters is discussed.
Medical subject headings
- Superior Vena Cava Syndrome
- Thrombolytic Therapy
- Urokinase-Type Plasminogen Activator